腾讯分分彩后二单计划_新腾讯分分彩个位计划_腾讯分分彩官方平台网站
 
Profile of Gansu ChanGee Bio-Pharmaceutical Limited Company

 

As a wholly-owned subsidiary of the listed company Shenzhen Hanyu  Pharmaceutical Co. Ltd,  the company is a large comprehensive enterprise in research and development, production and sales of drugs and medical equipment, and is an enterprises with the double certifications of Drug Production License and Medical Equipment Production License. The company has an area of 117 Mu, the greening rate of the factory is 48.68%, its registered capital is 229 million Yuan and has 67 patent technologies. The company has passed the new GMP certifications of national small-volume injection, lyophilized powder for injection and solid preparation. The company current possesses 171 national drug approval numbers and 9 medical device registration certificates. The company has 10 production lines, including low volume injection of ampicillin, lyophilized powder for injection, solid preparation, capsule, powder, sterile medical device. The company main engages into the research and development, production and sales of antitumor drugs, drugs of cardiovascular and cerebrovascular diseases, antibiotics, diabetes and other chronic diseases drugs, automatic injection and automatic dissolution series of medical devices.

 
 

 

腾讯分分彩后二单计划_新腾讯分分彩个位计划_腾讯分分彩官方平台网站


Copyright© Changee Bio-pharmaceutical co.,Ltd Tel:0755-26588033 18123858418 Fax:0755-26588033 Address:Nian Pu Industrial Zone,Maiji District Of Tianshui City,Gansu Province.P.C:741020